 |
Frederic Waldman, MD, PhD
Recent Publications |
Publications – 2009 |
 |
Crane, C.A., A. Panner, J.C. Murray,
S.P. Wilson, H. Xu, L. Chen, J.P. Simko, F.M.
Waldman, R.O.
Pieper, and A.T. Parsa, PI(3) kinase is associated with a
mechanism of immunoresistance in breast and prostate cancer.
Oncogene, 2009. 28(2): p. 306-12. |
| |
Publications – 2008 |
|
Choueiri, T.K., S.A. Vaziri, E. Jaeger,
P. Elson, L. Wood, I.P. Bhalla, E.J. Small, V. Weinberg,
N. Sein, J. Simko, A.R. Golshayan, L. Sercia, M. Zhou, F.M.
Waldman, B.I. Rini, R.M. Bukowski, and R. Ganapathi, von
Hippel-Lindau gene status and response to vascular endothelial
growth factor targeted therapy for metastatic clear cell
renal cell carcinoma. J Urol, 2008. 180(3): p. 860-5; discussion
865-6. |
|
Nickerson, M.L., E. Jaeger, Y. Shi,
J.A. Durocher, S. Mahurkar, D. Zaridze, V. Matveev, V. Janout,
H. Kollarova, V. Bencko, M. Navratilova, N. Szeszenia-Dabrowska,
D. Mates, A. Mukeria, I. Holcatova, L.S. Schmidt, J.R. Toro,
S. Karami, R. Hung, G.F. Gerard, W.M. Linehan, M. Merino,
B. Zbar, P. Boffetta, P. Brennan, N. Rothman, W.H. Chow,
F.M. Waldman, and L.E. Moore, Improved identification of
von Hippel-Lindau gene alterations in clear cell renal tumors.
Clin Cancer Res, 2008. 14(15): p. 4726-34. |
|
Raphael, B.J., S. Volik, P. Yu, C. Wu,
G. Huang, E.V. Linardopoulou, B.J. Trask, F.
Waldman, J.
Costello, K.J. Pienta, G.B. Mills, K. Bajsarowicz, Y. Kobayashi,
S. Sridharan, P.L. Paris, Q. Tao, S.J. Aerni, R.P. Brown,
A. Bashir, J.W. Gray, J.F. Cheng, P. de Jong, M. Nefedov,
T. Ried, H.M. Padilla-Nash, and C.C. Collins, A sequence-based
survey of the complex structural organization of tumor genomes.
Genome Biol, 2008. 9(3): p. R59. |
|
Signoretti, S., G. Bratslavsky, F.M.
Waldman, V.E. Reuter, J. Haaga, M. Merino, G.V. Thomas, M.R.
Pins, T. Libermann, J. Gillespie, J.E. Tomaszewski, C.C.
Compton, A. Hruszkewycz, W.M. Linehan, and M.B. Atkins, Tissue-based
research in kidney cancer: current challenges and future
directions. Clin Cancer Res, 2008. 14(12): p. 3699-705. |
|
Tutt, A., A. Wang, C. Rowland, C. Gillett,
K. Lau, K. Chew, H. Dai, S. Kwok, K. Ryder, H. Shu, R. Springall,
P. Cane, B. McCallie, L. Kam-Morgan, S. Anderson, H. Buerger,
J. Gray, J. Bennington, L. Esserman, T. Hastie, S. Broder,
J. Sninsky, B. Brandt, and F. Waldman, Risk estimation of
distant metastasis in node-negative, estrogen receptor-positive
breast cancer patients using an RT-PCR based prognostic expression
signature. BMC Cancer, 2008. 8: p. 339. |
| |
Publications – 2007 |
|
Adduci, K.M., C.E. Annis, S. DeVries, K.L.
Chew, J. Boutin, G. Magrane, B.M. Ljung, F.M. Waldman, and
L.J. Esserman, Fluorescence in situ hybridization of ductal
lavage samples identifies malignant phenotypes from cytologically
normal cells in women with breast cancer. Cancer, 2007. 111(3):
p. 185-91. |
|
Korkola, J.E., E. Blaveri, S. DeVries,
D.H. Moore, 2nd, E.S. Hwang, Y.Y. Chen, A.L. Estep, K.L.
Chew, R.H. Jensen, and F.M. Waldman, Identification of a
robust gene signature that predicts breast cancer outcome
in independent data sets. BMC Cancer, 2007. 7: p. 61. |
|
return
to top
|
|
|
|
|
|
